For citations:

Alekseev I.B., Abramova O.I., Kazantseva E.P. Comparison of the effectiveness and safety of monotherapy with 0.03% bimatoprost (Bimatan®) and 0.005% latanoprost (Xalatan®) in patients with primary open-angle glaucoma. National Journal glaucoma. 2021;20(1):26-31. (In Russ.) https://doi.org/10.25700/NJG.2021.01.03